Aug 21, 2019
At Lundbeck, we believe life is too precious to be interrupted by brain disorders. Lundbeck is uncompromisingly committed to the research, development and delivery of targeted therapies for people living with significant psychiatric and neurological disorders. We pursue imaginative solutions, driven by passionate people committed to do the right thing for our patients, our company and our communities. Lundbeck strives to be a leader in depression, schizophrenia, Alzheimer's disease and Parkinson's disease. For Lundbeck, making a meaningful difference for patients is more than an aspiration; it is a commitment that shapes everything we do. Patient advocacy is at the core of who we are and motivates every individual at Lundbeck. Our engagement with the communities we serve grants us better understanding of the needs of patients and their families; and that drives us to develop innovative therapies and impactful programs for patients and caregivers. Description Lundbeck La Jolla Research Center, Inc. (LLJRC) is a discovery research arm of H. Lundbeck A/S. Our mission is to develop innovative medicines that address significant unmet need in the treatment of psychiatric and neurological disorders. LLJRC is seeking a motivated neuroscientist to support preclinical stage programs in the portfolio. In this role, the successful candidate will be responsible for working with and leading project teams to validate novel CNS targets and characterize first-in-class small molecules to the drug candidate stage using cell-based and in vivo models. Experience in microglial biology and neuroinflammation is desirable but not mandatory. Your job and key responsibilities You will be a key contributor to multi-disciplinary project teams supporting target validation of novel CNS disease targets and the development of high quality small molecule therapeutics. You will be responsible for independently developing, performing and interpreting in vitro, cellular and in vivo pharmacology studies executed internally and/or at Contract Research Organizations (CROs). Approximately 75% of your work will be lab-based, focused on cellular and in vivo assays to evaluate mechanism of action of new drug candidates with an emphasis on microglia biology and models of neuroinflammation and neurodegeneration. You will also be responsible for data analysis, preparation of reports and presentations. We offer The opportunity to join a dynamic and energetic team of qualified colleagues working in an open atmosphere in a leading CNS specialized drug discovery organization. Required Qualifications and Skills Our preferred candidate has the following personal and professional qualifications; PhD and PostDoc in neuroscience, neurobiology or related area 0 – 3 years of experience in biotechnology or pharmaceutical drug discovery/development Demonstrated broad knowledge of CNS biology Excellent collaboration, communication, and presentation skills Both effective team player and strong individual contributor, flexible, and able to handle multiple tasks and deliver high quality results under tight timelines Some travel required to H. Lundbeck A/S in Valby, Denmark Preferred Qualifications and Skills In-depth knowledge of CNS disease models and elucidating small molecule mechanisms-of-action Expertise in microglial biology and experience with cellular and in vivo neuroinflammation models strongly desired Expertise in current technology platforms in CNS biology and neuroimmunology Lundbeck is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employement opportunity regardless of race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status, and any other characteristic protected by law, rule, or regulation. Lundbeck participates in E-Verify.
Lundbeck LLC San Diego, CA, USA